Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease

Jiafeng Pan (Corresponding Author), Kimberley Kavanagh, Kate Cuschieri, Kevin Pollock, Duncan C Gilbert, David Millan, Sarah Bell, Sheila V Graham, Alistair R. W. Williams, Margaret E Cruickshank, Tim Palmer, Katie Wakeham (Corresponding Author)

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

To assess the excess risk of HPV‐associated cancer (HPVaC) in two at‐risk groups – women with a previous diagnosis of high grade cervical intraepithelial neoplasia (CIN3) and both men and women treated for non‐cervical pre‐invasive ano‐genital disease. All CIN3 cases diagnosed in 1989‐2015 in Scotland were extracted from the Scottish cancer registry (SMR06). All cases of pre‐invasive penile, anal, vulval, and vaginal disease diagnosed in 1990‐2015 were identified within the NHS pathology databases in the two largest NHS health boards in Scotland. Both were linked to SMR06 to extract subsequent incidence of HPVaC following the diagnosis of CIN3 or pre‐invasive disease. Standardised incidence ratios were calculated for the risk of acquiring HPVaC for the two at‐risk groups compared with the general Scottish population. Among 69714 females in Scotland diagnosed with CIN3 (890360.9 person‐years), 179 developed non‐cervical HPVaC. CIN3 cases were at 3.2‐fold (95% CI: 2.7 to 3.7) increased risk of developing non‐cervical HPVaC, compared to the general female population. Among 1235 patients diagnosed with non‐cervical pre‐invasive disease (9667.4 person‐years), 47 developed HPVaC. Individuals with non‐cervical pre‐invasive disease had a substantially increased risk of developing HPVaC ‐ 15.5‐fold (95% CI: 11.1 to 21.1) increased risk for females and 28‐fold (11.3 to 57.7) increased risk for males. We report a significant additional risk of HPV‐associated cancer in those have been diagnosed with pre‐invasive HPV‐associated lesions including but not confined to the cervix. Uncovering the natural history of pre‐invasive disease has potential for determining screening, prevention and treatment.

This article is protected by copyright. All rights reserved.
Original languageEnglish
Pages (from-to)427-434
Number of pages8
JournalInternational Journal of Cancer
Volume145
Issue number2
Early online date4 Mar 2019
DOIs
Publication statusPublished - 15 Jul 2019

Fingerprint

Neoplasms
Scotland
Vaginal Diseases
Cervical Intraepithelial Neoplasia
Incidence
Cervix Uteri
Population
Registries
Databases
Pathology
Health
Therapeutics

Keywords

  • HPV
  • non-cervical genital cancer
  • data linkage

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pan, J., Kavanagh, K., Cuschieri, K., Pollock, K., Gilbert, D. C., Millan, D., ... Wakeham, K. (2019). Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease. International Journal of Cancer, 145(2), 427-434. https://doi.org/10.1002/ijc.32126

Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease. / Pan, Jiafeng (Corresponding Author); Kavanagh, Kimberley; Cuschieri, Kate; Pollock, Kevin; Gilbert, Duncan C; Millan, David; Bell, Sarah; Graham, Sheila V; Williams, Alistair R. W.; Cruickshank, Margaret E; Palmer, Tim; Wakeham, Katie (Corresponding Author).

In: International Journal of Cancer, Vol. 145, No. 2, 15.07.2019, p. 427-434.

Research output: Contribution to journalArticle

Pan, J, Kavanagh, K, Cuschieri, K, Pollock, K, Gilbert, DC, Millan, D, Bell, S, Graham, SV, Williams, ARW, Cruickshank, ME, Palmer, T & Wakeham, K 2019, 'Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease', International Journal of Cancer, vol. 145, no. 2, pp. 427-434. https://doi.org/10.1002/ijc.32126
Pan, Jiafeng ; Kavanagh, Kimberley ; Cuschieri, Kate ; Pollock, Kevin ; Gilbert, Duncan C ; Millan, David ; Bell, Sarah ; Graham, Sheila V ; Williams, Alistair R. W. ; Cruickshank, Margaret E ; Palmer, Tim ; Wakeham, Katie. / Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease. In: International Journal of Cancer. 2019 ; Vol. 145, No. 2. pp. 427-434.
@article{d2d8db49099f43b484d467336db757a0,
title = "Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease",
abstract = "To assess the excess risk of HPV‐associated cancer (HPVaC) in two at‐risk groups – women with a previous diagnosis of high grade cervical intraepithelial neoplasia (CIN3) and both men and women treated for non‐cervical pre‐invasive ano‐genital disease. All CIN3 cases diagnosed in 1989‐2015 in Scotland were extracted from the Scottish cancer registry (SMR06). All cases of pre‐invasive penile, anal, vulval, and vaginal disease diagnosed in 1990‐2015 were identified within the NHS pathology databases in the two largest NHS health boards in Scotland. Both were linked to SMR06 to extract subsequent incidence of HPVaC following the diagnosis of CIN3 or pre‐invasive disease. Standardised incidence ratios were calculated for the risk of acquiring HPVaC for the two at‐risk groups compared with the general Scottish population. Among 69714 females in Scotland diagnosed with CIN3 (890360.9 person‐years), 179 developed non‐cervical HPVaC. CIN3 cases were at 3.2‐fold (95{\%} CI: 2.7 to 3.7) increased risk of developing non‐cervical HPVaC, compared to the general female population. Among 1235 patients diagnosed with non‐cervical pre‐invasive disease (9667.4 person‐years), 47 developed HPVaC. Individuals with non‐cervical pre‐invasive disease had a substantially increased risk of developing HPVaC ‐ 15.5‐fold (95{\%} CI: 11.1 to 21.1) increased risk for females and 28‐fold (11.3 to 57.7) increased risk for males. We report a significant additional risk of HPV‐associated cancer in those have been diagnosed with pre‐invasive HPV‐associated lesions including but not confined to the cervix. Uncovering the natural history of pre‐invasive disease has potential for determining screening, prevention and treatment.This article is protected by copyright. All rights reserved.",
keywords = "HPV, non-cervical genital cancer, data linkage",
author = "Jiafeng Pan and Kimberley Kavanagh and Kate Cuschieri and Kevin Pollock and Gilbert, {Duncan C} and David Millan and Sarah Bell and Graham, {Sheila V} and Williams, {Alistair R. W.} and Cruickshank, {Margaret E} and Tim Palmer and Katie Wakeham",
note = "We acknowledge the patient representative (FT) for reviewing and commenting our manuscript. KW received funding from Merck Sharp & Dohme Limited. KC’s institution has received research funding and or consumables to support research from the following entities in the last 3 years—Hologic, Cepheid, Qiagen, Euroimmun, LifeRiver, Genomica,Gene-First and SelfScreen.",
year = "2019",
month = "7",
day = "15",
doi = "10.1002/ijc.32126",
language = "English",
volume = "145",
pages = "427--434",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease

AU - Pan, Jiafeng

AU - Kavanagh, Kimberley

AU - Cuschieri, Kate

AU - Pollock, Kevin

AU - Gilbert, Duncan C

AU - Millan, David

AU - Bell, Sarah

AU - Graham, Sheila V

AU - Williams, Alistair R. W.

AU - Cruickshank, Margaret E

AU - Palmer, Tim

AU - Wakeham, Katie

N1 - We acknowledge the patient representative (FT) for reviewing and commenting our manuscript. KW received funding from Merck Sharp & Dohme Limited. KC’s institution has received research funding and or consumables to support research from the following entities in the last 3 years—Hologic, Cepheid, Qiagen, Euroimmun, LifeRiver, Genomica,Gene-First and SelfScreen.

PY - 2019/7/15

Y1 - 2019/7/15

N2 - To assess the excess risk of HPV‐associated cancer (HPVaC) in two at‐risk groups – women with a previous diagnosis of high grade cervical intraepithelial neoplasia (CIN3) and both men and women treated for non‐cervical pre‐invasive ano‐genital disease. All CIN3 cases diagnosed in 1989‐2015 in Scotland were extracted from the Scottish cancer registry (SMR06). All cases of pre‐invasive penile, anal, vulval, and vaginal disease diagnosed in 1990‐2015 were identified within the NHS pathology databases in the two largest NHS health boards in Scotland. Both were linked to SMR06 to extract subsequent incidence of HPVaC following the diagnosis of CIN3 or pre‐invasive disease. Standardised incidence ratios were calculated for the risk of acquiring HPVaC for the two at‐risk groups compared with the general Scottish population. Among 69714 females in Scotland diagnosed with CIN3 (890360.9 person‐years), 179 developed non‐cervical HPVaC. CIN3 cases were at 3.2‐fold (95% CI: 2.7 to 3.7) increased risk of developing non‐cervical HPVaC, compared to the general female population. Among 1235 patients diagnosed with non‐cervical pre‐invasive disease (9667.4 person‐years), 47 developed HPVaC. Individuals with non‐cervical pre‐invasive disease had a substantially increased risk of developing HPVaC ‐ 15.5‐fold (95% CI: 11.1 to 21.1) increased risk for females and 28‐fold (11.3 to 57.7) increased risk for males. We report a significant additional risk of HPV‐associated cancer in those have been diagnosed with pre‐invasive HPV‐associated lesions including but not confined to the cervix. Uncovering the natural history of pre‐invasive disease has potential for determining screening, prevention and treatment.This article is protected by copyright. All rights reserved.

AB - To assess the excess risk of HPV‐associated cancer (HPVaC) in two at‐risk groups – women with a previous diagnosis of high grade cervical intraepithelial neoplasia (CIN3) and both men and women treated for non‐cervical pre‐invasive ano‐genital disease. All CIN3 cases diagnosed in 1989‐2015 in Scotland were extracted from the Scottish cancer registry (SMR06). All cases of pre‐invasive penile, anal, vulval, and vaginal disease diagnosed in 1990‐2015 were identified within the NHS pathology databases in the two largest NHS health boards in Scotland. Both were linked to SMR06 to extract subsequent incidence of HPVaC following the diagnosis of CIN3 or pre‐invasive disease. Standardised incidence ratios were calculated for the risk of acquiring HPVaC for the two at‐risk groups compared with the general Scottish population. Among 69714 females in Scotland diagnosed with CIN3 (890360.9 person‐years), 179 developed non‐cervical HPVaC. CIN3 cases were at 3.2‐fold (95% CI: 2.7 to 3.7) increased risk of developing non‐cervical HPVaC, compared to the general female population. Among 1235 patients diagnosed with non‐cervical pre‐invasive disease (9667.4 person‐years), 47 developed HPVaC. Individuals with non‐cervical pre‐invasive disease had a substantially increased risk of developing HPVaC ‐ 15.5‐fold (95% CI: 11.1 to 21.1) increased risk for females and 28‐fold (11.3 to 57.7) increased risk for males. We report a significant additional risk of HPV‐associated cancer in those have been diagnosed with pre‐invasive HPV‐associated lesions including but not confined to the cervix. Uncovering the natural history of pre‐invasive disease has potential for determining screening, prevention and treatment.This article is protected by copyright. All rights reserved.

KW - HPV

KW - non-cervical genital cancer

KW - data linkage

UR - http://www.scopus.com/inward/record.url?scp=85062610749&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/increased-risk-hpvassociated-genital-cancers-men-women-consequence-preinvasive-disease

U2 - 10.1002/ijc.32126

DO - 10.1002/ijc.32126

M3 - Article

VL - 145

SP - 427

EP - 434

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -